| Literature DB >> 25024337 |
Antón Alvarez1, Manuel Aleixandre2, Carlos Linares3, Eliezer Masliah4, Herbert Moessler5.
Abstract
Reduced brain-derived neurotrophic factor (BDNF) signaling is considered as a pathogenic event in early Alzheimer's disease (AD), but the influence of apathy and apolipoprotein E ε4 allele (APOE4) on serum BDNF values was not previously investigated in AD. We evaluated serum BDNF levels in AD, amnestic mild cognitive impairment (MCI), and control subjects. Baseline BDNF levels were similar in AD, MCI, and controls. AD patients having apathy showed lower BDNF values than patients without apathy (p < 0.05). After correction for the influence of apathy, APOE4 carriers showed lower BDNF levels (p < 0.01) and MMSE scores (p < 0.01) than non-APOE4 carriers in the subgroup of AD females, but not in males. Significant (p < 0.05) positive correlations between BDNF values and MMSE scores were only observed in subgroups of AD males and of AD patients without apathy. These results are showing the association of apathy and APOE4 with reduced serum BDNF levels in AD, and are suggesting that BDNF reductions might contribute to the worse cognitive performance exhibited by AD apathetic patients and female APOE4 carriers.Entities:
Keywords: Alzheimer's disease; apathy; apolipoprotein E ε4 allele; brain-derived neurotrophic factor; elderly control subjects; mild cognitive impairment; serum
Mesh:
Substances:
Year: 2014 PMID: 25024337 PMCID: PMC4931817 DOI: 10.3233/JAD-140849
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472